Can a chat with a doctor cut drug costs? study tests education to boost cheaper meds
NCT ID NCT07221890
Summary
This study is testing if educational visits to doctors can encourage them to prescribe lower-cost 'biosimilar' versions of a common drug (adalimumab) for conditions like rheumatoid arthritis and Crohn's disease. Researchers will compare doctors who receive the educational outreach to those who do not, to see if it changes their prescription habits. The goal is to see if this type of education can help reduce medication costs for patients and the healthcare system.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLAMMATORY BOWEL DISEASE (IBD) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
-
Humana Healthcare Research, Inc.
Louisville, Kentucky, 40202, United States
Conditions
Explore the condition pages connected to this study.